Loading...
UK Trademark — IPO
NOVELLUS
Application UK00918006607 · Registered
Quick Facts
| Application Number | UK00918006607 |
| Status | Registered |
| Owner | Factor Bioscience LLC |
| Filed | 2019-01-04 |
| Registered | 2019-06-13 |
| Renewal Due | 2029-01-04 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. NOVELLUS is currently a registered UK trademark, with renewal due on 2029-01-04. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Pharmaceuticals; Gene therapy preparations, tests or reagents; chemical reagents for medical and veterinary purposes; Gene therapy preparations, tests or reagents, that apply gene-editing technology that uses de novo-engineered gene-editing proteins expressed with synthetic messenger ribonucleic acid; synthetic messenger ribonucleic acid preparations for medical and veterinary purposes and related chemical reagents for medical and veterinary purposes for correcting deficient or defective genes; synthetic ribonucleic acid preparations, tests or reagents encoding natural or engineered nucleases, zinc-finger nucleases, meganucleases, nickases, and transcription activator like effector nucleases for in vivo and in vitro genetic engineering; Cell therapy preparations, tests or reagents; Cell therapy preparations, tests or reagents, that use cell reprogramming technology that uses reprogramming factors expressed with synthetic messenger ribonucleic acid; synthetic messenger ribonucleic acid preparations for medical and veterinary purposes and related chemical reagents for medical and veterinary purposes for reprogramming cells; synthetic ribonucleic acid preparations, tests or reagents encoding reprogramming factors; pharmaceutical products for converting non-pluripotent cells into pluripotent stem cells, with or without gene-editing.
Class 42 — Scientific & IT Services
Pharmaceutical research and development services; Pharmaceutical research and development services in the field of production of cell therapies, with or without gene-editing and with or without messenger ribonucleic acid engineering; Pharmaceutical research and development services, namely, gene-editing services, messenger ribonucleic acid engineering services, cell reprogramming services, and cell therapy development services; scientific laboratory services, namely, stem cell production services; scientific laboratory services in the field of production of stem cells and converting non-pluripotent cells into pluripotent stem cells, with or without gene-editing; scientific laboratory services, namely, gene-editing services.
Timeline
- Filed: 2019-01-04
- Registered: 2019-06-13
- Renewal due: 2029-01-04
About This Trademark
'NOVELLUS' is a registered trademark on the UK IPO register, owned by Factor Bioscience LLC. The application (UK00918006607) was filed on 4 January 2019 and registered on 13 June 2019. The registration is set to expire on 4 January 2029.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services).
The trademark is represented by Morgan, Lewis & Bockius UK LLP.
Frequently Asked Questions
Who owns UK trademark UK00918006607 ('NOVELLUS')?
UK trademark UK00918006607 for the mark 'NOVELLUS' in Class 5, 42 is recorded on the UK IPO register as owned by Factor Bioscience LLC. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00918006607 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00918006607 for the mark 'NOVELLUS' as registered.
Which Nice classes is UK trademark UK00918006607 registered under?
UK trademark UK00918006607 for the mark 'NOVELLUS' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceuticals; Gene therapy preparations, tests or reagents; chemical reagents for medical and veterinary purposes; Gene therapy preparations, tests or reagents, that apply gene-editing technology that uses de novo-engineered gene-editing proteins expressed with synthetic messenger ribonucleic acid; synth…
When was UK trademark UK00918006607 filed?
UK trademark UK00918006607 for the mark 'NOVELLUS' was filed at the UK IPO on 4 January 2019 and registered on 13 June 2019.
When does UK trademark UK00918006607 need to be renewed?
UK trademark UK00918006607 for the mark 'NOVELLUS' is currently recorded as valid until 4 January 2029, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00918006607?
Morgan, Lewis & Bockius UK LLP is listed as the attorney / representative of record for UK trademark UK00918006607 for the mark 'NOVELLUS' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "NOVELLUS" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| NOVELLUSSame applicant | 88028436 | 700 | 2018-07-06 |
| NOVELLUS | 98778951 | 688 | 2024-09-30 |
| NOVELLUS | 88328139 | 700 | 2019-03-06 |
| NF NOVELLUS FINANCIAL | 86225475 | 710 | 2014-03-19 |
| NOVELLUS CAPITAL MANAGEMENT | 77168179 | 710 | 2007-04-27 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.